Xcout Intel
Chiesi Farmaceutici
Chiesi Farmaceutici is a global biopharmaceutical group that researches, develops, and commercializes therapeutic solutions for patients. The company focuses primarily on respiratory health, rare diseases, and specialty care.
Subscribe to see Chiesi Farmaceutici’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Chiesi Farmaceutici at a glance
Chiesi Farmaceutici is a pharmaceuticals company headquartered in Italy. Xcout tracks 5 named people at Chiesi Farmaceutici, including Alessandro Chiesi (Vicepresidente).
Chiesi Farmaceutici leadership
- Alessandro ChiesiVicepresidente
- Maria Paola ChiesiPresidente del CdA
- Anna Bonisoli AlquatiHead of Global External Communications
- Davide PaterliniGlobal External Communications Sr. Manager
- Michela LijoiGlobal External Communications Sr. Manager
Recent Chiesi Farmaceutici news
- PartnershipPartner with us
Chiesi Farmaceutici competitors
A few of Chiesi Farmaceutici's closest competitors — see the full list of competitors and alternatives →
Recordati is a global pharmaceutical company that develops and commercializes medicines for both common and rare diseases. It serves patients across approximately 150 countries through its specialty, primary care, and rare diseases operations.
Ferring Pharmaceuticals is a specialty biopharmaceutical company that develops and delivers treatments in reproductive medicine, maternal health, gastroenterology, urology, and uro-oncology. The company focuses on helping people build families, supporting maternal and infant health, and providing therapeutic solutions for various medical conditions worldwide.
CSL Vifor is part of the global biotechnology company CSL, focusing on the development and delivery of medical treatments for patients. Specifically, the company specializes in addressing therapeutic areas such as iron deficiency and nephrology.
Novo Nordisk is a global healthcare company that researches, develops, manufactures, and markets pharmaceutical products. It primarily provides treatments and medical solutions for chronic conditions such as diabetes, obesity, and rare blood and endocrine disorders to serve patients and healthcare professionals.
Verona Pharma plc focuses on innovative respiratory treatments and is headquartered in London, UK, alongside offices in the United States.
Menarini is a global pharmaceutical company headquartered in Florence, Italy. It has three divisions: Menarini Ricerche, Menarini Biotech, and Menarini Diagnostics, and focuses on developing pharmacological products.
Get Chiesi Farmaceutici's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Chiesi Farmaceutici in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access